Reshaping
Diagnostics

Changing and improving the method and efficiency through innovative technologies to reshaping diagnostics for everyone at everywhere with high quality medical services.

News

Reshaping Diagnostics
for Everyone Everywhere

Changing and improving the method and efficiency through innovative technologies to reshaping diagnostics for everyone at everywhere with high quality medical services.

Our History

Our history traced back to 2014, when a research team composed of postdoctoral fellows and scientists from multiple prestigious universities and institutions in the United States, including two postdoctoral fellows from the Lawrence Berkeley National Laboratory, a postdoctoral fellow from the California Department of Public Health, a professor from McMaster University, as well as Dr. Joshua Robinson and Academician Hongjie Dai from the U.S. National Academy of Sciences, was established in Joinn Innovation Park, located in the heart of Silicon Valley, California, USA. In the same year of November, we had research cooperation with Nirmidas and StartX (Stanford’s Accelerator) on Personal and Portable Health Diagnostic Testing. In the following year, our first colloidal analyzer passed the test from DCN, the authorized device test organization in the US.

2014

Our research and development continued in the next few years with encouraging results by steady progress. In 2016, we developed colloidal gold test strip product antibodies in collaboration with ProMab and 2 patents obtained in the same year. In the next 3 years, we updated the version each year from Colloidal analyzer 2.0 version, Second Generation of colloidal analyzer: EHB-2.3 to version EHB3.0-EBH3.1.

2016

When the COVID pandemic prevailed in 2020, our core team decided to move back to Germany. The R&D continued until our first hematology analyzer based on cell morphology technology came alive in 2021. Our brand story started by then…

2021

Our History

Our history traced back to 2014, when a research team composed of postdoctoral fellows and scientists from multiple prestigious universities and institutions in the United States, including two postdoctoral fellows from the Lawrence Berkeley National Laboratory, a postdoctoral fellow from the California Department of Public Health, a professor from McMaster University, as well as Dr. Joshua Robinson and Academician Hongjie Dai from the U.S. National Academy of Sciences, was established in Joinn Innovation Park, located in the heart of Silicon Valley, California, USA. In the same year of November, we had research cooperation with Nirmidas and StartX (Stanford’s Accelerator) on Personal and Portable Health Diagnostic Testing. In the following year, our first colloidal analyzer passed the test from DCN, the authorized device test organization in the US.

Our research and development continued in the next few years with encouraging results by steady progress. In 2016, we developed colloidal gold test strip product antibodies in collaboration with ProMab and 2 patents obtained in the same year. In the next 3 years, we updated the version each year from Colloidal analyzer 2.0 version, Second Generation of colloidal analyzer: EHB-2.3 to version EHB3.0-EBH3.1.

When the COVID pandemic prevailed in 2020, our core team decided to move back to Germany. The R&D continued until our first hematology analyzer based on cell morphology technology came alive in 2021. Our brand story started by then…

Certificates

Our Certification

Multi-Application Scenarios

Multi-application scenarios refer to situations where a system or technology is designed to be used across various contexts or applications. This requires the system to be versatile and adaptable to meet the diverse needs of different use cases.

Hospital

Quickly and accurately analyze blood samples to diagnose various medical conditions.

Laboratory

Our easy-to-use blood testing device provides rapid, precise results, enabling personalized laboratory treatments and improving client satisfaction.

Clinic

Our user-friendly blood testing device offers quick, accurate results, enhancing patient care and operational efficiency in the clinic.

Our Advantages

AI Reshaping Diagnostics

Powered by image recognition and deep learning, our AI generates morphology reports within 6 minutes, accurately identifying abnormal cells and redefining hematology diagnostics with trusted clinical insights.

Maintenance-Free

With an innovative no-liquid pipeline design, our analyzers require no daily cleaning and eliminate clogging risks. Single-use dry reagent cards need no cold-chain storage, cutting maintenance costs and saving time and labor.

Multi-Functional Integration

One analyzer integrates CBC, immunoassay, dry biochemistry, urine, and feces testing. Versatile across clinics, pharmacies, ERs, research labs, and veterinary practices, it delivers true all-in-one functionality.

Globally Validated

Headquartered in Germany with R&D and production centers in China and UAE, Ozelle has over 50,000 installations and 40M+ samples tested worldwide, clinically validated against leading international systems.

What People
Say About Us

Our products are popular among doctors around the world.

“With the EHBT-50, I finally have hematology, immunoassay, and biochemistry tests all in one device. It saves space in my clinic and makes diagnostics so much faster.”
Dr. Anna Müller, Family Physician
“The AI-driven cell morphology is impressive. It helps me catch abnormalities I might have overlooked and gives me more confidence in every report.”
Dr. James Wong, Community Hospital
“Running routine tests feels as easy as using a smartphone. The system is simple, intuitive, and I don’t waste time on maintenance anymore.”
Maria Lopez, General Practitioner
“Patients appreciate that results are available within minutes. It makes follow-up discussions on treatment much more effective.”
Liam Carter, Pharmacist
“What I like most about the EHBT-50 is its precision. Even in our busy environment, the results are reliable, and that accuracy makes all the difference.”
Dr. Sophie Dubois, Pediatrician
“What stands out for me is the robustness. We’ve tested the EHBT-50 in different conditions, and the precision remains consistent. It’s a device built with real craftsmanship.”
Prof. David Chen, Laboratory Director

Login

Require a Demo

Kindly provide your contact details so that we can reach out to you and arrange a demonstration. You can also reach us via the phone number and email address provided at the bottom.

info@ozellepoct.com